No such provisions in accordance with Article 24 of the TRIPS Agreement in the Trademarks Act.

At present, the IP framework does not extend to the protection of designs dictated by technical or functional considerations. No provisions are available for protection of textile designs either.

At present, there are no protections for rights holders against imported items bearing embodied or copied designs.

The current legislation does not provide for the right to issue compulsory licenses for industrial designs.

There is currently no protection for industrial designs.

At present, the legislation does not define any of these terms.

Section 3 of the Patents Act provides that every inventor is entitled to the sole exclusive right of and in his invention. This Act does not prescribe any exclusions to the enjoyment of patent rights.

The Patents Act does not provide for the exclusion of patentability based on ordre public or morality. Please note, however, that the Trademark Act per section 10 restricts registration of "…a trade-mark or part of a trade-mark any matter the use of which would, by reason of its being calculated to deceive or otherwise, be disentitled to protection in a court of justice or would be contrary to law or morality, or any scandalous design."

At present, diagnostic, therapeutic, and surgical methods are not excluded from patentability in Fiji's legislation.

At present, plants, animals and essentially biological processes are not excluded from patentability in Fiji's legislation.

At present, micro-organisms, non-essentially biological processes, microbiological processes and plant varieties are not protected in the current legislation.

At present, there are no provision for protection of rights holders against the importing and against the offering for sale of a patented invention.

At present, the Patents Act does not provide protection of pharmaceutical and agricultural chemical products. In fact, section 3A provides that pharmaceutical products and substances are exceptions to infringement of patent rights.

The legislation does not cover the patent protection of a process or the product obtained directly by that process.

There are no additional conditions other than the sufficient disclosure required in making the petition for a letters patent.

As stated above, Section 3A provides that "it is not an infringement of patents in pharmaceuticals for any person to make, construct, use or sell the patented invention in respect of a pharmaceutical product or substance, solely for uses reasonably related to the development and submission of information required under any law of the Fiji Islands or of another country that regulates the manufacture, construction, use or sale of such pharmaceutical product or substance."

At present, the Patents Act does not provide for compulsory licensing.

At present, the Patents Act does not provide for a proposed user to obtain authorization from a right holder.

At present, Section 4 of the Patents Act only allows 14 years of patent protection and there are no additional protections after this period has lapsed.

The Patents Act does not provide for enhanced protection of patents or patent applications pending on 01/01/1995.